These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 36408231)

  • 1. Corrigendum: Artemisinin reduces PTSD-like symptoms, improves synaptic plasticity, and inhibits apoptosis in rats subjected to single prolonged stress.
    Liu Q; Ding X; Wang Y; Chu H; Guan Y; Li M; Sun K
    Front Pharmacol; 2024; 15():1427681. PubMed ID: 38957386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corrigendum: NmFGF1-regulated glucolipid metabolism and angiogenesis improves functional recovery in a mouse model of diabetic stroke and acts via the AMPK signaling pathway.
    Zhao Y; Ye S; Lin J; Liang F; Chen J; Hu J; Chen K; Fang Y; Chen X; Xiong Y; Lin L; Tan X
    Front Pharmacol; 2024; 15():1392148. PubMed ID: 38828458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: Xenon attenuated neonatal lipopolysaccharide exposure induced neuronal necroptosis and subsequently improved cognition in juvenile rats.
    Liao Z; Ou X; Zhou C; Ma D; Zhao H; Huang H
    Front Pharmacol; 2024; 15():1438335. PubMed ID: 39050761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Advances in the study of acetaminophen-induced liver injury.
    Li X; Ni J; Chen L
    Front Pharmacol; 2023; 14():1283596. PubMed ID: 37808184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy.
    Zhang Y; Sheng Z; Xiao J; Li Y; Huang J; Jia J; Zeng X; Li L
    Front Pharmacol; 2023; 14():1345663. PubMed ID: 38155900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: Could peripheral 5-HT level be used as a biomarker for depression diagnosis and treatment? A narrative minireview.
    Li C; Cai Q; Su Z; Chen Z; Cao J; Xu F
    Front Pharmacol; 2023; 14():1318433. PubMed ID: 38026939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study.
    Chun GY; Mohd Tahir NA; Islahudin F; Selvaratnam V; Li SC
    Front Pharmacol; 2023; 14():1336072. PubMed ID: 38074118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab in the treatment of glucocorticoid-induced osteoporosis.
    Coskun Benlidayi I
    Rheumatol Int; 2018 Nov; 38(11):1975-1984. PubMed ID: 30019224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model.
    Pizzino G; Irrera N; Galfo F; Oteri G; Atteritano M; Pallio G; Mannino F; D'Amore A; Pellegrino E; Aliquò F; Anastasi GP; Cutroneo G; Squadrito F; Altavilla D; Bitto A
    Front Pharmacol; 2022; 13():1073618. PubMed ID: 36408231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model.
    Pizzino G; Irrera N; Galfo F; Oteri G; Atteritano M; Pallio G; Mannino F; D'Amore A; Pellegrino E; Aliquò F; Anastasi GP; Cutroneo G; Squadrito F; Altavilla D; Bitto A
    Front Pharmacol; 2017; 8():558. PubMed ID: 28928654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis.
    Pallio G; Bitto A; Pizzino G; Galfo F; Irrera N; Squadrito F; Squadrito G; Pallio S; Anastasi GP; Cutroneo G; Macrì A; Altavilla D
    Front Pharmacol; 2022; 13():1073445. PubMed ID: 36438841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Pharmacological activity and clinical use of PDRN.
    Squadrito F; Bitto A; Irrera N; Pizzino G; Pallio G; Minutoli L; Altavilla D
    Front Pharmacol; 2022; 13():1073510. PubMed ID: 36479198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Polydeoxyribonucleotide, an adenosine-A2
    Squadrito F; Micali A; Rinaldi M; Irrera N; Marini H; Puzzolo D; Pisani A; Lorenzini C; Valenti A; Laurà R; Germanà A; Bitto A; Pizzino G; Pallio G; Altavilla D; Minutoli L
    Front Pharmacol; 2022; 13():1073543. PubMed ID: 36467092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Activation of A2A receptor by PDRN reduces neuronal damage and stimulates WNT/β-catenin driven neurogenesis in spinal cord injury.
    Irrera N; Arcoraci V; Mannino F; Vermiglio G; Pallio G; Minutoli L; Bagnato G; Anastasi GP; Mazzon E; Bramanti P; Squadrito F; Altavilla D; Bitto A
    Front Pharmacol; 2022; 13():1073726. PubMed ID: 36408237
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.